Literature DB >> 2539242

Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies.

P C Burger1, P Kleihues.   

Abstract

To study the progression of astrocytic neoplasms and to provide practical information about the topography of the glioblastoma multiforme, the distribution of eight defined cell types was mapped from whole brain sections of 18 glioblastomas studied postmortem. Based on the densities and topographic distributions of well-differentiated and anaplastic cells, three principal categories of neoplasms were defined. In one group of three cases, multifocal glioblastomas appeared to be emerging in the background of a better differentiated, and presumably precursory, astrocytic neoplasm. In another group of nine cases, the neoplasms were more intimate mixtures of well and poorly differentiated cells. The third group of five cases was composed of neoplasms that were largely undifferentiated without a component of better differentiated cells. The study suggests that progression from a better differentiated neoplasm to one composed largely of undifferentiated cells is common in the fibrillary astrocytic neoplasms. Although some glioblastomas appear largely undifferentiated and consistent with the de novo appearance of overt malignancy, the size of these neoplasms and the patterns of necrosis leave open the possibility that a preexisting better differentiated neoplasm had been obliterated by necrosis and the overgrowth of the anaplastic component. The potential topographic variation of cellular constituency in a glioblastoma underscores the care that must be exercised in utilization of the needle biopsy technique in the diagnosis and grading of astrocytic neoplasms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539242     DOI: 10.1002/1097-0142(19890515)63:10<2014::aid-cncr2820631025>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner.

Authors:  Hannah S Picariello; Rajappa S Kenchappa; Vandana Rai; James F Crish; Athanassios Dovas; Katarzyna Pogoda; Mariah McMahon; Emily S Bell; Unnikrishnan Chandrasekharan; Amanda Luu; Rita West; Jan Lammerding; Peter Canoll; David J Odde; Paul A Janmey; Thomas Egelhoff; Steven S Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

2.  A model for optimizing delivery of targeted radionuclide therapies into resection cavity margins for the treatment of primary brain cancers.

Authors:  Raghu Raghavan; Roger W Howell; Michael R Zalutsky
Journal:  Biomed Phys Eng Express       Date:  2017-05-05

Review 3.  Angiogenesis in brain tumors; pathobiological and clinical aspects.

Authors:  P Wesseling; D J Ruiter; P C Burger
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

4.  Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.

Authors:  Yu Liang; Maximilian Diehn; Nathan Watson; Andrew W Bollen; Ken D Aldape; M Kelly Nicholas; Kathleen R Lamborn; Mitchel S Berger; David Botstein; Patrick O Brown; Mark A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-12       Impact factor: 11.205

5.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

Authors:  C K Goldman; J Kim; W L Wong; V King; T Brock; G Y Gillespie
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

6.  Glioblastoma Stem Cells: A Neuropathologist's View.

Authors:  Roger E McLendon; Jeremy N Rich
Journal:  J Oncol       Date:  2010-11-01       Impact factor: 4.375

Review 7.  Brain tumor stem cells as therapeutic targets in models of glioma.

Authors:  Dan Richard Laks; Koppany Visnyei; Harley Ian Kornblum
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

8.  A multi-resolution textural approach to diagnostic neuropathology reporting.

Authors:  Mohammad Faizal Ahmad Fauzi; Hamza Numan Gokozan; Brad Elder; Vinay K Puduvalli; Christopher R Pierson; José Javier Otero; Metin N Gurcan
Journal:  J Neurooncol       Date:  2015-08-09       Impact factor: 4.130

Review 9.  A role for the NG2 proteoglycan in glioma progression.

Authors:  William B Stallcup; Feng-Ju Huang
Journal:  Cell Adh Migr       Date:  2008-07-13       Impact factor: 3.405

10.  The role of myosin II in glioma invasion of the brain.

Authors:  Christopher Beadle; Marcela C Assanah; Pascale Monzo; Richard Vallee; Steven S Rosenfeld; Peter Canoll
Journal:  Mol Biol Cell       Date:  2008-05-21       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.